Bli medlem
Bli medlem

Du är här


Annual General Meeting 2015: Tecan shareholders endorse all motions proposed by the Board of Directors

Tecan Group AG / Annual General Meeting 2015: Tecan shareholders endorse all
motions proposed bythe Board of Directors . Processed and transmitted by
NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the
content of this announcement.
* Dividend of CHF 1.50 per share
* Rolf Classon, Heinrich Fischer, Oliver Fetzer, Karen Huebscher, Christa
Kreuzburg and Gérard Vaillant re-elected as members of the Board of
* Lars Holmqvist elected as a new member of the Board of Directors
* Rolf Classon confirmed by shareholders as Chairman of the Board
* Oliver Fetzer and Christa Kreuzburg confirmed as members of the
Compensation Committee
* All proposals relating to compensation approved

Männedorf, Switzerland, April 16, 2015 -
The Annual General Meeting of Tecan Group Ltd. (SIX Swiss Exchange: TECN) has
today endorsed all motions proposed by the Board of Directors. Shareholders
approved the Annual Report, the financial statements and the consolidated
financial statements, and granted discharge to the Board of Directors and the
Management Board. They also approved a dividend of CHF 1.50 per registered
share, unchanged versus the previous year. The payout will take place on
April 22, 2015.

All members of the Tecan Board of Directors who stood for re-election were
confirmed by the shareholders for a term of one year: Heinrich Fischer, Dr.
Oliver Fetzer, Dr. Karen Huebscher, Dr. Christa Kreuzburg, Gérard Vaillant
and Rolf Classon. Rolf Classon was re-elected as Chairman of the Board of
Directors. The shareholders also confirmed Oliver Fetzer and Christa
Kreuzburg as members of the Compensation Committee.

The Annual General Meeting elected Lars Holmqvist as a new member of the Board
of Directors. Lars Holmqvist, 56, a Swedish national, brings more than 25
years' international experience within the medical device, pharmaceutical and
life science industries, where he held roles in marketing, sales and business
management. Most recently, he was President of the Life Sciences and
Diagnostics Group and Senior Vice President at Agilent Technologies Inc.

The Chairman bid farewell to Erik Walldén, who decided not to stand for
re-election after four years on the Board of Directors, and thanked him for
his valuable service.

KPMG AG, Zurich, was reappointed as the statutory auditors for fiscal 2015.

Shareholders approved the motion proposed by the Board of Directors to appoint
Proxy Voting Services GmbH, Zurich, as the independent proxy for the period
up to the close of the Tecan Group 30th Annual General Meeting in 2016.

All proposals relating to compensation approved

For the first time, shareholders voted on the conditions governing the
compensation of the Board of Directors and Management Board for the following
fiscal year, in line with the amendments to the Articles of Incorporation
adopted in the previous year. The Company submitted two separate proposals to
the Annual General Meeting for the Management Board. One of these proposals
concerned the fixed salary and additional components relating to fiscal 2016.
The second proposal related to Tecan Group's existing long-term incentive
plan. The shareholders made a binding decision to endorse all proposed
motions on the maximum total amount of compensation for 2016. The
compensation report, which was submitted for an advisory vote for the fourth
time, was also accepted by shareholders.

Next key date

Tecan will publish the 2015 Interim Report on August 12, 2015.

About Tecan

Tecan ( is a leading global provider of laboratory instruments
and solutions in biopharmaceuticals, forensics and clinical diagnostics. The
company specializes in the development, production and distribution of
automated workflow solutions for laboratories in the life sciences sector.
Its clients include pharmaceutical and biotechnology companies, university
research departments, forensic and diagnostic laboratories. As an original
equipment manufacturer (OEM), Tecan is also a leader in developing and
manufacturing OEM instruments and components that are then distributed by
partner companies. Founded in Switzerland in 1980, the company has
manufacturing, research and development sites in both Europe and North
America and maintains a sales and service network in 52 countries. In 2014,
Tecan generated sales of CHF 400 million (USD 437 million; EUR 331 million).
Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN;
ISIN CH0012100191).

For further information:

Tecan Group

Martin Brändle
Vice President, Communications&Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89

Press Release


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.